Your browser doesn't support javascript.
loading
Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage.
Szekely, Jidapa; Swangphon, Piyawut; Nanakorn, Natthaphon; Chaimuti, Panuttha; Nualnoi, Teerapat; Wongwitwichot, Paweena; Somapa, Namchoke; Somapa, Denpong; Pengsakul, Theerakamol.
Afiliación
  • Szekely J; Faculty of Medical Technology, Prince of Songkla University, Hat Yai 90110, Thailand.
  • Swangphon P; Faculty of Medical Technology, Prince of Songkla University, Hat Yai 90110, Thailand.
  • Nanakorn N; Faculty of Medical Technology, Prince of Songkla University, Hat Yai 90110, Thailand.
  • Chaimuti P; Immunology and Virology Unit, Department of Medical Technology and Clinical Pathology, Hat Yai Hospital, Hat Yai 90110, Thailand.
  • Nualnoi T; Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai 90110, Thailand.
  • Wongwitwichot P; Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai 90110, Thailand.
  • Somapa N; Master Labs Incorporation Co., Ltd., Bangkok 10510, Thailand.
  • Somapa D; Master Labs Incorporation Co., Ltd., Bangkok 10510, Thailand.
  • Pengsakul T; Faculty of Environmental Management, Prince of Songkla University, Hat Yai 90110, Thailand.
Vaccines (Basel) ; 11(7)2023 Jul 11.
Article en En | MEDLINE | ID: mdl-37515045

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Suiza